Adam Feuerstein articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2015/07/28 20:22
2015/07/28 20:22
1d
FOSTER CITY, Calif. (TheStreet) -- Gilead Sciences(GILD - Get Report) will not be blamed for a cooling of the biotech bull market, if any such thing exists. Second-quarter earnings and revenue topped...
2015/07/28 20:22
2015/07/28 20:22
Latest videos
2015/07/28 15:22
2015/07/28 15:22
1d
NEW YORK (TheStreet) -- It's a day that ends in "day," which means cancer immunotherapy is dominating the biotech news. Len is Leonard Schleifer, CEO of Regeneron Pharmaceuticals , the large-cap...
2015/07/27 15:22
2015/07/27 15:22
2d
... Will Biogen buy itself back into investors' good graces? Isis Pharmaceuticals (ISIS) might be the most obvious Biogen takeout target given its existing partnership, but is it the smart move?...
2015/07/20 18:22
2015/07/20 18:22
9d
The FDA's calendar of 2015 Advisory Committee Tentative Meetings was just updated with a Nov. 23-24 slot for the Peripheral and Central Nervous System Drugs Advisory Committee, which is the expert...
2015/07/18 04:17
2015/07/18 04:17
12d
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class...
2015/07/13 16:22
2015/07/13 16:22
16d
FOSTER CITY, Calif. (TheStreet) -- The total number of prescriptions written for Gilead Sciences (GILD - Get Report) hepatitis C drugs Sovaldi and Harvoni in the U.S. peaked in March and are now in a...
2015/07/07 12:22
2015/07/07 12:22
22d
Under terms of the all-stock deal, Horizon proposes to acquire Depomed for $29.95 per share, or a 42% premium to the closing price of Depomed on July 6. The deal, if closed, would be accretive...
2015/07/04 01:17
2015/07/04 01:17
26d
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class...
2015/07/02 17:22
2015/07/02 17:22
27d
BOSTON ( TheStreet) -- This week's Biotech Stock Mailbag is abbreviated and delivered a day early due to the Fourth of July. Happy hot dogs and fireworks, everyone! Nothing yet, and Juno's almost...
2015/06/29 21:22
2015/06/29 21:22
30d
Under terms of the 10-year collaboration, Celgene is buying 9.1 million shares of Juno at $93 per share -- a 102% premium to Juno's closing price of $46.30. Juno will also receive a $150 million...
Read more at TheStreet.com, CNBC
2015/06/26 22:17
2015/06/26 22:17
m
IsoRay manufactures isotope-based medical products for the treatment of cancer and other malignant diseases. The Company produces Proxcelan Cesium-131 brachytherapy seeds for the treatment of various...
2015/07/28 20:22
2015/07/28 20:22
Latest from Twitter